CannPal's Approach to Research and Development
Animal Health company CannPal Animal Therapeutics Limited (ASX:CP1) Chief Scientific Adviser Dr Rayson Tan introduces the Company’s approach to research and development.
Dr Tan highlights CannPal’s competitive advantage and how the Compnay expects to benefit from engaging gene expression profiling.
To learn more please visit: http://cannpal.com/
Dr Tan highlights CannPal’s competitive advantage and how the Compnay expects to benefit from engaging gene expression profiling.
To learn more please visit: http://cannpal.com/
People In This Video
No users are tagged in this video